Research Article
Metabolic Syndrome and Hypertension Resulting from Fructose Enriched Diet in Wistar Rats
Table 1
Effects of fructose supplementation on abdominal fat weight, liver weight, heart weight, theoretical creatinine clearance, and plasma urea, ASAT, ALAT, albumin, and lipid levels. FF: fructose fed; C: control.
| | C
| FF
| |
| Heart weight (% bw) | 0.274 ± 0.005 | 0.281 ± 0.006 | 0.37 | Abdominal fat weight (% bw) | 3.86 ± 0.27 | 5.04 ± 0.24 | 0.0029 | Liver weight (% bw) | 2.39 ± 0.06 | 2.68 ± 0.06 | 0.0016 | Plasma urea (mg/L) | 409.9 ± 18.6 | 300.2 ± 13.3 | 0.0001 | ASAT/ALAT | 2.01 ± 0.12 | 2.42 ± 0.18 | 0.36 | Theoretical creatinine clearance (mL/min) | 2.13 ± 0.07 | 2.08 ± 0.05 | 0.60 | NEFA (µmol/L) | 532.6 ± 15.7 | 627.5 ± 50.1 | 0.34 | Triglycerides (mg/L) | 836.0 ± 67.0 | 1393.9 ± 113.7 | 0.0004 | Total cholesterol (mg/L) | 779.6 ± 37.2 | 795.8 ± 21.4 | 0.69 | NEFA/total cholesterol (molar ratio) | 0.274 ± 0.014 | 0.307 ± 0.024 | 0.27 | NEFA/albumin (molar ratio) | 1.071 ± 0.033 | 1.208 ± 0.093 | 0.61 | Total cholesterol/triglycerides (molar ratio) | 2.33 ± 0.23 | 1.42 ± 0.09 | 0.0005 |
|
|